The Pivotal Study is a prospective, single-arm, multicenter clinical study to assess the long-term safety and effectiveness of aXess, our vascular access graft for patients with chronic kidney disease (CKD) requiring hemodialysis, based on our proprietary endogenous tissue restoration (ETR) platform.
To find out more about the Pivotal Study and how to enrol, see our trial website here: axesspivotal.com
